parkinson's disease

Weekly Psychedelic Links - October 2022

10.7.22

Cannabis

  • Biden Announces Mass Marijuana Pardons And Calls For Cannabis Scheduling Review (Marijuana Moment)

  • Amsterdam considers banning ‘cannabis tourists’ from its coffee shops (The Guardian)

  • Costa Rica’s President Sends Marijuana Legalization Bill To Lawmakers (Marijuana Moment)

  • 'It's like the new Amsterdam': The rush to cash in on Thailand's hazy cannabis laws (Australian Broadcasting Corporation)

  • FBI: Nearly Half of All Drug Seizures in 2021 Involved Marijuana (NORML)

  • Morocco issues first permits for cannabis production (Reuters)

  • Committee in Colombia Approved Adult-Use Legalization Proposal (High Times)

  • Most Americans Don’t Think Marijuana Is Dangerous Despite Prohibitionist Arguments, Poll Finds (Marijuana Moment)

  • Regulators finally approve hempcrete for US homes (Leafly)

  • OSHA report ties cannabis worker death to dust inhalation (Leafly)

  • Survey: Medical Students Rarely Exposed to Scientific Data About Cannabis (NORML)

Magic Mushrooms

  • Oregon enters the home stretch to authorize psilocybin mushrooms (Chacruna)

  • This 'magic' mushroom dispensary in Florida is selling psychedelics and testing legal boundaries (Business Insider)

MDMA

  • MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA (Psychedelic Alpha)

DMT

Ayahuasca

Novel Psychoactive Substances

  • These LSD-based drugs seem to help mice with anxiety and depression — without the trip (NPR)

  • Are you too high? A promising new ‘comedown drug’ may be on the way (Leafly)

Synthetic Cannabinoids

  • Unexplained Bleeding Linked to Rat Poison in Synthetic Cannabinoids (Medpage Today)

Nitrous Oxide

  • Nitrous oxide: Southend mum's campaign over 'laughing gas' (BBC)

Ketamine

  • Ketamine and depression: A mechanism of the antidepressant revealed (Medical Xpress)

  • PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s Disease (Psychedelic Alpha)

Miscellaneous

  • Alberta to be 1st province to regulate psychedelics for therapy, government says (CBC)

  • DEA Admits ‘Racial, Ethnic and Class Prejudice’ Led To Drug Criminalization And The Agency’s Own Founding (Marijuana Moment)

  • New York Lawmakers File Amended Psychedelics Legalization Bill, With New Regulations And Protections (Marijuana Moment)

  • Psychedelics may flatten your brain’s landscape, but in a good way (Leafly)

  • Inflammation Nation: How Psychedelics Could Combat Widespread Chronic Pain (Psychedelics Today)

  • Psychedelics: Will Policy Liberalization and Lower Barriers to Access Lead to Future Legalization? (Lexpert)

  • Psychedelics are exploding in the startup community as founders say it makes them better leaders (Fortune)

  • Timothy Leary’s psychedelic eugenics (Medium)

  • Eleusis Holdings Plans To Be Acquired By Beckley Psytech (Lucid News)

  • ‘Bad’ Psychedelic Trips Don’t Have To Be Bad (VICE)

10.14.22

Cannabis

  • Colombian Chamber Of Representatives Passes Marijuana Legalization Bill In Initial Vote, With Support From Cabinet Ministers (Marijuana Moment)

  • U.S. Air Force to Allow Applicants to Retest After Positive THC Test (High Times)

  • Why bees love weed — and why it might even be good for them (Salon)

  • Cannabis Stock’s Post Pardon Depression Could Be Cured By Lame Duck Legislation (Forbes)

  • New Study Shows Cannabis Users More Likely To Have Overactive Bladders (High Times)

  • Federal Reserve Bank Says Marijuana Legalization Drives Tax Revenue, Job Creation And Real Estate Sales (Marijuana Moment)

  • Spliff Vape: New Tech Allows Cannabis, Nicotine To Be Vaped Simultaneously (High Times)

Magic Mushrooms

  • Flight Passenger on Mushrooms Causes Chaos Mid-Flight (High Times)

  • Can Psilocybin Challenge Our Pharmaceutical Dependence? (Vogue)

MDMA

  • Eels Living Near Music Festivals Test Positive For MDMA And Cocaine (IFLScience)

Synthetic Cannabinoids

  • Synthetic Marijuana In Florida Tainted With Rat Poison, 52 Sick, 4 Dead (Forbes)

  • Five-Year-Old Missouri Child Gets Delta-8 Edibles in Halloween Bag (High Times)

Nitrous Oxide

  • Nitrous Oxide: Harm Reduction and the Muslim Community (VolteFace)

Miscellaneous

  • These States Are Voting On Marijuana And Psychedelics Legalization On Their November Ballots (Marijuana Moment)

  • Elon Musk reportedly goes on 'exploratory journeys' and likes to show friends a chart of the benefits of MDMA and mushrooms over alcohol (Business Insider)

  • To Standardize Psychedelic Therapy, A New Organization Launches (Forbes)

  • Horizons Conference Returns to NYC for Its 15th Year (Lucid News)

  • Treating postpartum depression with psychedelics (The Print)

  • A Santo Daime Church’s Legal Success Paved a Path Towards Psychedelic Legalization (Lucid News)

  • Instagram’s Page-Deletions of Black Women in Psychedelic Advocacy (Filter)

  • Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3 (Psychedelic Spotlight)

  • What Made María Sabina Unique (DoubleBlind)

  • The Politics of Psychedelics: Legalisation vs Decriminalisation (Sam Woolfe)

10.21.22

Cannabis

  • German cannabis legalisation plans LEAKED (VolteFace)

  • Washington DC lets tourists self-certify for medical cannabis (Leafly)

  • Poll: Two-Thirds of Voters Say “Nobody Should Be in Jail” for Marijuana Possession (NORML)

  • States With the Most Arrests for Marijuana Possession (U.S. News and World Report)

  • Why does marijuana make it hard to remember stuff? (Salon)

  • NBA Won’t Test Players For Marijuana For Third Season In A Row, Report Says (Marijuana Moment)

  • Nearly Four Out of Five Patients Drop or Reduce Opioids After Using Medical Weed (High Times)

  • Brazilian Federal Council of Medicine Bans CBD Prescriptions for Adult Patients (TalkingDrugs)

  • Cannabis Had Highest Tax Revenue in Colorado and Washington Over Alcohol, Cigarettes (High Times)

  • Marijuana was illegal 4 years ago. Now, Uber Eats delivers it in Toronto (CBC)

  • Missouri Police Object To New Ad For Marijuana Legalization Ballot Initiative That Shows Officers (Marijuana Moment)

  • Oklahoma Governor Sets March Special Election for Weed Legalization Initiative (High Times)

  • Texas Activists Unveil Marijuana Decriminalization, Police Reform And Abortion Rights Initiative For San Antonio 2023 Ballot (Marijuana Moment)

  • Puerto Rico Bill Would Expunge Low-Level Weed Possession Convictions (High Times)

LSD

Magic Mushrooms

  • Oregon is voting on medical psilocybin, again (Leafly)

  • NYC smoke shops are selling magic mushroom candy bars (New York Post)

  • Study To Examine Why Shrooms Evolved with Psychedelic Properties (High Times)

  • Why Everyone Cares So Much About Colorado’s Psilocybin Bill (DoubleBlind)

MDMA

  • MDMA-assisted psychotherapy shows promise in the treatment of eating disorder symptoms (PsyPost)

5-MeO-DMT

  • The toad boom: the false narrative of ancestral 5-MeO-DMT use (Points)

Novel Psychoactive Substances

  • Scientists Discover ‘Disconcerting’ New Imitation Ketamine on the Market (VICE)

Synthetic Cannabinoids

Ketamine

  • Ketamine May Reduce Suicidal Ideation in Treatment-Resistant Depression (Psychiatry Advisor)

Miscellaneous

  • Australian Lawmakers Approve Drug Decriminalization Bill For Federal Territory That Includes Nation’s Capital (Marijuana Moment)

  • DEA Proposes Dramatic Increases In Marijuana And Psychedelics Production In 2023 For Research (Marijuana Moment)

  • Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development (PsyPost)

  • Will Medical Insurers Agree to Cover Psychedelic Trips? (Bloomberg)

  • Why is the American right suddenly so interested in psychedelic drugs? (The Guardian)

  • Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio (Psychedelic Alpha)

10.28.22

Cannabis

  • Germany’s Government Approves Marijuana Legalization Plan, But Reform Depends On European Union Sign-Off (Marijuana Moment)

  • Russian court upholds Brittney Griner’s sentence (Leafly)

  • Biden's Marijuana Pardons Did Not Free a Single Federal Prisoner or Deliver the Expungement He Promised (Reason)

  • Activist Arrested At White House Protest Pushing Biden To Release Marijuana Prisoners (Marijuana Moment)

  • Missouri’s legalization measure is drawing unexpected opposition (Leafly)

  • Five States To Vote on Recreational Cannabis This Election Season (High Times)

  • Most Americans Say Alcohol And Tobacco Are More Dangerous Than Marijuana, Poll Finds (Marijuana Moment)

  • California Lawsuit Alleges Weed Didn't Get Plaintiffs High Enough (VICE)

  • Research: Does Cannabis Really Make You More Creative? (Harvard Business Review)

  • Israeli Company Clones Cannabis Cells—Not Plants—With Up to 12 Times the Potency (High Times)

  • It's not a myth: Marijuana really is more potent than it used to be (Salon)

  • Study: Cannabis Use Not A Risk Factor in Liver Transplants (High Times)

  • Strange Bedfellows Team Up To Oppose Missouri Marijuana Legalization Ballot Measure (Marijuana Moment)

  • Research Shows Cannabis Users Experience More Pain After Surgery (High Times)

  • Support For Arkansas Marijuana Legalization Initiative Falls To Slim Majority As GOP Lawmakers Urge Opposition, Poll Finds (Marijuana Moment)

  • How does THC affect prenatal development? (Leafly)

Magic Mushrooms

  • The world's first Phase 3 psilocybin clinical trial is about to commence (New Atlas)

  • DEA Faces New Legal Challenges Over Denying Psilocybin Rescheduling Petition And Doctor’s Federal Waiver Request (Marijuana Moment)

  • New Study Will Explore Psilocybin as a Treatment To Stop Smoking (High Times)

  • N.S. company launching clinical trial to examine magic mushrooms as treatment for PTSD (CBC)

  • The Potential Health Benefits of Microdosing Psilocybin With Chocolate (Psychology Today)

  • Psilocybin Common Denominator in Several Recent Albums (High Times)

DMT

  • Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study (Psychedelic Alpha)

Ayahuasca

Peyote

  • Native American Church Asks Congress for Peyote Funding (DoubleBlind)

Novel Psychoactive Substances

  • WTF is 3-MMC, Berlin’s Weird New Club Drug? (DoubleBlind)

  • Electric Picnic drug testing finds 'new psychoactive substances' never seen before in Ireland (The Irish Mirror)

Synthetic Cannabinoids

  • Utah Medical Cannabis Flooded With Synthetic Cannabinoids From Hot Hemp (Forbes)

Ketamine

  • Electroconvulsive Therapy Could Be Better Than Ketamine At Treating Depression (IFLScience)

Miscellaneous

  • Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited (Psychedelic Alpha)

  • People Who Use Psychedelics Are More Connected To Nature And Knowledgeable About Climate Change, Study Finds (Marijuana Moment)

  • Use of Psychedelic Therapies for Treatment Resistant Patients Again Rejected by Government, Despite Strong Supporting Safety and Efficacy Data and Australia’s Worsening Mental Health Crisis (Mind Medicine Australia)

  • With Promise of Legalization, Psychedelic Companies Joust Over Future Profits (The New York Times)

  • Manipulating light can induce psychedelic experiences – and scientists aren’t quite sure why (The Conversation)

  • The ideological war at the heart of the psychedelic renaissance (New Atlas)

  • Research, remedy and regulation: the changing dynamics of psychedelic therapy in Alberta (CBC)

  • An Exploration of Psychedelics and Creativity (Drug Science)

  • Variants in 5-HT2A Receptor Gene Alter Psychedelic Pharmacology (Psychedelic Science Review)

  • Guidelines for Ethical Sponsorship and Transparency in Psychedelic Conferences (Chacruna)

  • Terence McKenna's secret bad trip (Ecstatic Integration)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Weekly Psychedelic Links - July 2022

7.1.22

Cannabis

  • Fentanyl-laced marijuana is a myth. It’s time to end the hype (Leafly)

  • Medical Weed Cards No Longer Required in Virginia Starting July 1 (High Times)

  • Hemp, CBD get permanent legal status in NC after 11th-hour rescue (MSN.com)

  • Scientists find THC in over 60% of CBD products they tested — and that may be a huge problem (ZME Science)

  • UN Report Dramatizes Uptick in Global Cannabis Use (High Times)

  • Louisiana Governor Signs Bill Providing Medical Marijuana Workplace Protections For State Employees (Marijuana Moment)

  • Maryland Court: Cops Can Stop, Question Someone Who Smells of Pot (High Times)

  • Nevada Cannabis Consumption Lounges Could Go Live By End Of 2022 (Marijuana Moment)

  • Edibles, beverages infused with cannabis ingredient THC become legal Friday in Minnesota (Star Tribune)

  • Inside The Process To Legalize Recreational Cannabis In Germany (Forbes)

  • California Bill to Require Cannabis Warnings About Mental Disorder Risks Advances (High Times)

  • Pennsylvania Lawmakers Advance Medical Marijuana DUI Protections And Cannabis Banking Reform Bills (Marijuana Moment)

  • Texas Supreme Court Bans Smokable Hemp Production, Sales (High Times)

  • Montana Lawsuit Challenges Marijuana Ban In State’s Third-Largest City (Marijuana Moment)

  • House Panel Approves Amendment to Protect State Legal Cannabis Programs (High Times)

  • Feds Fund Development Of Hemp-Based, 3D-Printed Materials To Build Affordable Housing (Marijuana Moment)

  • New Vermont Guidance Looks to Eliminate Plastic Waste From State’s Cannabis Industry (High Times)

  • Cannabis users are at greater risk for emergency and inpatient care: study (Fox News)

Magic Mushrooms

  • These Mormons Have Found a New Faith — in Magic Mushrooms (Rolling Stone)

  • New Jersey Senate President Files Psilocybin Legalization Bill That Includes Home Grow Option, Unlike Current Marijuana Law (Marijuana Moment)

  • Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge Eating Disorder Treatment (Psychedelic Alpha)

  • Digging Up Druggable Targets: Psilocybin Efficacy in a Model of OCD (Psychedelic Science Review)

MDMA

  • First-of-its-kind MDMA group therapy trial set to commence (New Atlas)

  • Over One Hundred Years of MDMA Research (Drug Science)

Ayahuasca

  • How the Shipibo Came to Be the Most Common Group Serving Ayahuasca to Foreigners (DoubleBlind)

Peyote

  • Decriminalize Nature Targets Peyote: Drug Reform or Settler Colonialism? (Chacruna)

  • Big business could wipe out Mexico’s sacred psychedelic peyote cactus (openDemocracy)

Novel Psychoactive Substances

  • How Did A Minnesota Honor Roll Student Die As Her Parents Were Sleeping Upstairs? (Oxygen)

Synthetic Cannabinoids

  • A Loophole in Japan’s Weed Laws Is Getting Tens of Thousands High (VICE)

Miscellaneous

  • Colorado Activists Turn In Signatures To Put Psychedelics Legalization And Therapeutic Psilocybin Program On Ballot (Marijuana Moment)

  • War on drugs prolonged Colombia’s decades-long civil war, landmark report finds (The Guardian)

  • Is there a future for psychedelic treatment in Saudi Arabia? (Arab News)

  • Do Bad Psychedelic Patents Matter? (Lucid News)

  • 4 Recommendations for Disability Inclusion in Psychedelic Therapy Research (Psychiatric Times)

7.8.22

Cannabis

  • WNBA Star Brittney Griner Pleads Guilty To Cannabis Charge As Russia Calls Out U.S. Hypocrisy In Maintaining Criminalization (Marijuana Moment)

  • Make no mistake, marijuana edibles are legal now in Minnesota (Leafly)

  • Washington, D.C. Mayor Signs Medical Cannabis Self-Certification Bill (High Times)

  • Pennsylvania Bill Gives Medical Cannabis Patients DUI Protection (High Times)

  • Oklahoma: Advocates Turn in Signatures to Place Adult-Use Legalization Measure on November Ballot (NORML)

  • Study Shows Flower Still Reigns Supreme in U.S., Canada as Consumer Favorite (High Times)

  • Arkansas Activists Set To Turn In Double The Signatures Needed To Put Marijuana Legalization On Ballot (Marijuana Moment)

  • Nebraska Medical Marijuana Activists Turn In Ballot Signatures After Campaign Suffers Legal Setback (Marijuana Moment)

  • Albania Prompted to Implement Medical Cannabis Reform After U.N. Criticism (High Times)

  • U.S. Army Wants To Make Sniper Uniforms Out Of Hemp (Marijuana Moment)

LSD

  • A man whose daily headaches felt like an ice pick in his eyes says he tried 12 treatments but only found relief after taking LSD (Insider)

Magic Mushrooms

  • New Study Shows Mood, Mental Health Improved by Microdosing Psilocybin (High Times)

  • Indiana Nurse Faces Ten Years in Prison for Microdosing Psilocybin Mushrooms (Psychedelic Spotlight)

  • Two Cancer Patients Battle to Make Psilocybin Accessible for Palliative Care (Scientific American)

  • Rural Oregon counties are lining up against psilocybin launch (OPB)

MDMA

  • Alexandria Ocasio-Cortez Pushes for Psychedelic Reform in Congress (DoubleBlind)

  • GOP Congressman’s Amendment Would Direct Military To Study Psilocybin And MDMA Benefits For Service Members (Marijuana Moment)

DMT

  • Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study (Psychedelic Alpha)

Iboga

  • ‘To Heal and to Care for’: Protecting Iboga and Indigenous Voices in the Face of Corporatisation (Volteface)

Novel Psychoactive Substances

  • DEA Announces Hearing On Proposed Ban Of Five Psychedelic Compounds Following Significant Pushback (Marijuana Moment)

  • Mindset Pharma Receives Allowance for Patent Application Covering its Short-Duration Novel Psychedelic Medications for The Treatment of Central Nervous System Disorders (Psychedelic Alpha)

Ketamine

  • PharmaTher Announces Positive Results from Study For Ketamine Microneedle Patch (Psychedelic Alpha)

Miscellaneous

  • The Never-Ending Psychedelic Trip of Michael Pollan (Rolling Stone)

  • Journey Colab scores $12M to move psychedelics-based addiction treatment into clinic (Fierce Biotech)

  • User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study (Drug Science)

  • Tripping the Reward Circuit: Psychedelics for Substance Use Disorders (Psychedelic Science Review)

  • Psychedelics Give a Glimpse of Enlightenment (Psychology Today)

7.15.22

Cannabis

  • Feds Must Defend Historical Rationale Of Banning Guns For Medical Marijuana Patients, Revised Lawsuit Argues After SCOTUS Ruling (Marijuana Moment)

  • ‘Green way of life’: Thailand sees cannabis boom after law change (Al Jazeera)

  • Washington DC just legalized weed for all adults—but it’s locals only (Leafly)

  • Oklahoma, North Dakota, Arkansas, and Nebraska submit signatures to put cannabis on November ballot (Leafly)

  • Study Shows Decrease in Heavy Truck Crash Rates Since Cannabis Legalization (High Times)

  • NYPD Will Keep Testing Officers For Marijuana, Reversing Course Hours After Announcing Policy Change Mandated By City (Marijuana Moment)

  • Cannabis Laws in France Have Disproportionately Affected Muslims (High Times)

  • New York Firefighters Won’t Be Tested For Marijuana, Department Says Following NYPD Leak (Marijuana Moment)

  • Argentine Supreme Court Endorses Medical Cannabis Home Grow (High Times)

  • Pennsylvania Governor Signs Marijuana Banking And Insurance Reform Bill Into Law (Marijuana Moment)

  • Portland Weed Demand Hits Three-Year Low (High Times)

  • Pennsylvania Police Arrested Over 13,000 People for Marijuana Possession in 2021 (NORML)

  • The Fight for Medical Cannabis in Indonesia (High Times)

  • Weed, Like Change, Nourishes The Soil To Regenerate The Cannabis Industry (Forbes)

LSD

  • Why David Bowie wasn’t a fan of LSD (Far Out)

Magic Mushrooms

  • DEA May Find Itself In Federal Court Again Over Refusal To Provide Psilocybin Access To Terminally Ill Patients (Marijuana Moment)

  • Oregon therapeutic psilocybin program sparks some confusion (OPB)

MDMA

  • World's first ecstasy 'shop' set to trial in the Netherlands (Mixmag)

  • Luxury Champagne Recalled Again Over Ecstacy Contamination (Newsweek)

  • MDMA: Rolling from Counterculture to the Clinic Counter (Psychedelic Science Review)

Ayahuasca

  • Study suggests ayahuasca users tend to eat healthier, get more exercise, and experience physical and mental health benefits (PsyPost)

Ketamine

  • PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders (Psychedelic Alpha)

Miscellaneous

  • Ann Shulgin, Forerunner of Today's Psychedelic Re-Emergence, Dies at 91 (Transform Press)

  • House Approves Marijuana And Psychedelics Amendments As Part Of Must-Pass Defense Bill (Marijuana Moment)

  • What Ethnographers Have Learned from People Who Use Drugs (Undark)

  • Inside the Chemistry Lab Where the MDMA Godfather Synthesized Novel Psychedelics (DoubleBlind)

  • The Tory Leadership Candidates on Drugs (Volteface)

  • Filament Health Issued Third Patent By United States Patent and Trademark Office (Psychedelic Alpha)

  • Doctors Urge Access to Psychedelic Therapies in New Mexico (TIME)

  • Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So. (Lucid News)

  • Villain Or Victim? Understanding The Role of Women In The Latin American Drug Trade (TalkingDrugs)

  • San Francisco’s New DA Vows to Ramp Up City’s Drug War (Filter)

  • The Battle for Psychedelic Patents (Psychedelic Spotlight)

  • How To Become a Psychedelic Therapist (DoubleBlind)

  • 5 Countries Where Psychedelics are Legal (Psychedelic Spotlight)

7.22.22

Cannabis

  • Senate Leadership Introduces Legislation to End Federal Marijuana Prohibition (NORML)

  • District of Columbia: Mayor Signs Legislation Prohibiting Most Employers from Discriminating Against Cannabis Consumers (NORML)

  • Legal cannabis is producing more plastic waste than pot (Leafly)

  • Colorado Company To Research Cannabis As A Treatment For Parkinson’s Disease (Forbes)

  • Biden Says He’s ‘Working On’ Bill To Release Cannabis Inmates (High Times)

  • Germany, Luxembourg, Malta And The Netherlands Discuss Marijuana Legalization At Historic Joint Meeting (Marijuana Moment)

  • Colorado Springs Recreational Cannabis Initiative Qualifies for November Ballot (High Times)

  • Minnesota Is Home To America's First Cannabis Disc Golf Course (MIX 108)

  • House Passes Bill Permitting Weed Ads on TV and Radio (High Times)

  • Colorado's New Lead Marijuana Monitor Treks Through Heavy Issues (Westword)

  • Cannabis Telemedicine Launches in Montana (High Times)

  • Montana Marijuana Businesses Face Seemingly Endless Cycle Of Local Votes On Allowing Them To Operate (Marijuana Moment)

  • People Busted for Weed in the U.K. Could Lose Passports Under Proposed Rules (High Times)

  • Missouri Marijuana Legalization Measure In Danger Of Not Qualifying For Ballot (Marijuana Moment)

  • Denver officials want to save struggling cannabis delivery businesses (The Denver Post)

  • Study Finds Australians Support Cannabis Use Over Smoking Tobacco (High Times)

  • House Will Not Vote On Marijuana Amendments For Veterans And Public Housing Residents After Committee Snag (Marijuana Moment)

  • Marijuana use is higher among US states that have legalized recreational cannabis use (News-Medical)

LSD

  • The Doors of Expression: LSD Alters Epigenetics and Protein Induction (Psychedelic Science Review)

  • Science Feature: MindMed’s LSD Trial for ADHD (Microdose)

  • Watch John Lennon explain that 'Lucy in the Sky with Diamonds' was not about LSD (Far Out)

Magic Mushrooms

  • The Sloppy Science of Psilocybin Microdosing Surveys (Psychedelic Spotlight)

  • A single dose of psilocybin has long-lasting antidepressant-like effects in fruit flies (PsyPost)

  • Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up (Scientific American)

MDMA

  • Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review (CBC)

  • 'Corrective' measures ordered, but Health Canada says 2nd MDMA trial can continue (CBC)

DMT

  • Teenager Used LSD And DMT To Help Overcome Trauma, Case Report Says (IFLScience)

Ayahuasca

  • Churches sue to use hallucinogenic tea in religious practice (UPI)

  • The Global Ayahuasca Boom: What About the Conservation of the Ayahuasca Vine? (Chacruna)

5-MeO-DMT

  • The Story Behind a 1984 Hallucinogenic Pamphlet From Denton Is Just as Trippy as Its Subject (Dallas Observer)

Novel Psychoactive Substances

  • Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs (Psychedelic Alpha)

Synthetic Cannabinoids

  • Weed vapes probably sending a toxic gas to your lungs, study finds (Salon)

  • Cannabis getting stronger with synthetic versions added leading to psychosis, report warns (Independent.ie)

Ketamine

  • Largest-ever clinical study of ketamine therapy shows that at-home model can be a safe, effective treatment for anxiety and depression; 62% fewer patients report suicidal ideation after four sessions (PR Newswire)

  • Ketamine Beneficial For Treating Neonatal, And Pediatric Epilepsy: Study (Medical Dialogues)

Miscellaneous

  • The Long, Strange Relationship Between Psychedelics and Telepathy (VICE)

  • DEA Sued Over ‘Unlawful’ Delays On Psychedelic And Marijuana Public Records Requests Through FOIA (Marijuana Moment)

  • Colorado Psychedelics Legalization Measure Qualifies for November Ballot (DoubleBlind)

  • Keeping the Hippie Dream Alive (The New York Times)

  • Accessibility Is Key for the Psychedelic Revolution (Pharmacy Times)

  • Podcast aims to raise awareness about future of psychedelic treatments (CBC)

  • Skip the trip – does the world need non-hallucinogenic psychedelics? (leafie)

  • New Regulations for Psychedelics? Here's What Investors Need to Know (The Motley Fool)

7.29.22

Cannabis

  • Weedmaps again advertising illegal marijuana retailers and products, complaints allege (Marijuana Business Daily)

  • Singapore Executes Man for Cannabis Trafficking (High Times)

  • House Passes Bipartisan Marijuana Research Bill, With Senate Expected To Send It To President Soon (Marijuana Moment)

  • Zimbabwe OKs First Medicinal Cannabis Sales (High Times)

  • Secret Australian marijuana facility exposes location after turning sky pink (The Washington Post)

  • Biden Administration Proposes Prisoner Swap To Free Brittney Griner (High Times)

  • Over 850 Doctors in Thailand Protest Pot Legalization (High Times)

  • Senator Files Bill To Allow Marijuana Advertising On TV And Radio In Legal States (Marijuana Moment)

  • The 'World's Biggest Cannabis Scam' Is Totally Unravelling (VICE)

  • Bronx Cannabis Hub Fosters Opportunity in Communities Hit Hard by Arrests (Filter)

  • Cannabis Users Less Likely to Face Complications After Spinal Fusion Surgery (High Times)

  • 15 State Attorneys General File Brief Opposing Lawsuit To Help Put Medical Marijuana On Nebraska Ballot (Marijuana Moment)

  • Thai businesses cash in on cannabis, from milk tea to toothpaste (Reuters)

  • Missouri Marijuana Legalization Initiative Short Of Signatures Needed For Ballot In County Reviews (Marijuana Moment)

  • New Hampshire stands alone in New England as only state without legal marijuana (WMUR)

LSD

  • New Zealand Government Grants $650K For LSD Microdosing Trials (Benzinga)

  • Operation Julie: Rural Wales LSD bust becomes a musical (BBC)

Magic Mushrooms

  • DEA Sued Again Over Refusal To Allow Psilocybin Access For Patients Despite Federal Law (Marijuana Moment)

  • Why some of Colorado’s foremost shrooms advocates won’t be voting to legalize psilocybin (The Denver Post)

  • Legal psilocybin prescriptions in Canada (Drug Science)

  • Project Solace: The World’s Largest Medical Psilocybin Access and Data Project (Psychedelic Spotlight)

  • COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa (Psychedelic Alpha)

DMT

  • U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation (Psychedelic Alpha)

Novel Psychoactive Substances

  • DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits (Marijuana Moment)

  • Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals (STAT News)

  • Festival drugs: Warning over 'imposter' substances threat (BBC)

  • Ecstasy for the 21st Century: Designer Drugs to Improve MDMA Therapy (Psychedelic Science Review)

Synthetic Cannabinoids

  • Easy On The Eyes — This Company Reports Using a Unique Synthetic Cannabinoid Derivative To Treat Glaucoma (Benzinga)

Nitrous Oxide

  • Doctors warn ‘dangerous’ laughing gas is becoming an ‘epidemic’ amid rise in hospitalisations (The Independent)

  • A Law will Prohibit the Sale of Nitrous Oxide or “Laughing Gas” to Minors in Bulgaria (Novinite.com)

Ketamine

  • At Home Sublingual Ketamine Exhibits Rapid And Significant Antidepressant And Anxiolytic Effects (Medical Dialogues)

  • Ketamine found to be unlikely to lead to addiction (Medical Xpress)

  • Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine (Psychedelic Alpha)

Miscellaneous

  • Biden Administration Plans For Legal Psychedelic Therapies Within Two Years (The Intercept)

  • San Francisco Launches Bid to Decriminalize Psychedelics (Filter)

  • Your Genes May Determine How You React To Psychedelic Drugs (IFLScience)

  • The Psychoactive Substances Act on Trial (Volteface)

  • The High-Stakes Race to Engineer New Psychedelic Drugs (WIRED)

  • Trump Urges ‘Very Quick Trial’ and Death Penalty for Drug Dealers (High Times)

  • The Psychedelics Industry’s Next Hurdle Is How to Go Mainstream (Bloomberg)

  • One in four Americans say they’ve tried at least one psychedelic drug (YouGov)

  • Microdosing: Scientists tackle psychedelic trend becoming ‘creative enhancer of choice’ (The Sydney Morning Herald)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.25.22

Cannabis

  • Federal Marijuana Legalization Bill Officially Scheduled For House Floor Vote Next Week (Marijuana Moment)

  • Rwanda Begins Cannabis Production (High Times)

  • New Hampshire Lawmakers Approve State-Run Marijuana Legalization Bill With Amendments, Sending It Back To House Floor (Marijuana Moment)

  • South Dakota: Governor Signs Legislation Preserving Patients’ Home Cultivation Rights (NORML)

  • U.S. Senate Unanimously Approves Marijuana Reform Bill On Same Day That House Schedules Legalization Vote (Marijuana Moment)

  • New York’s Cayuga Nation To Sell Recreational Cannabis (High Times)

  • What Do Joe Biden’s Cannabis Policy And Seinfeld Have In Common? Nothing. Literally. (Forbes)

  • After Surge Of Deadly Robberies At Marijuana Shops In Washington State, Officials Push For Federal Banking Reform (Marijuana Moment)

  • Study raises questions about risks of using medical marijuana for mood and anxiety disorders (CNN)

  • Group Launches Petition to Bring Recreational Pot to Colorado Springs (High Times)

  • Can cannabis ward off nightmares? Here’s what we know about how weed affects dreams (GreenState)

LSD

Magic Mushrooms

  • Hawaii Senators Amend Psilocybin Study Resolution To Make Access Contingent On Federal Approval (Marijuana Moment)

  • Psilocybin Is Effective in Reducing Weight Gain, New Study Shows (Psychedelic Spotlight)

  • Missouri looks to legalize shrooms (KMOV)

  • Stargazer Mushroom Strain: Cultivation, Effects, & More (DoubleBlind)

  • Beyond Psilocybin: These Mushrooms May Offer Brain-Boosting Compounds, Too (Discover)

  • Optimi Health Begins Cultivation Of Natural Psilocybin For Use In Clinical Trials (GlobeNewswire)

MDMA

  • MDMA Therapy for PTSD Looks Safe and Effective in New Trial Data (Gizmodo)

  • MDMA assisted therapy significantly reduces eating disorder symptoms (leafie)

  • You Won’t Feel High After Watching This Video (The Cut)

5-MeO-DMT

  • Demand for This Toad’s Psychedelic Toxin Is Booming. Some Warn That’s Bad for the Toad. (The New York Times)

Ketamine

Miscellaneous

  • The US Gets Its First Free, Rapid Drug-Checking Mail Program (Filter)

  • Utah Governor Signs Bill To Study Use Of Psychedelics For Mental Health Therapy (Marijuana Moment)

  • Another Michigan City Approves Psychedelics Decriminalization As Activists Pursue Statewide Ballot Measure (Marijuana Moment)

  • The Brave New World of Legalized Psychedelics Is Already Here (The Nation)

  • Another Psychedelics Company Is Crashing (Psychedelic Spotlight)

  • Connecticut Lawmakers Advance Psychedelics Therapy Bill (High Times)

  • Three Bills Seek to Shift Psychedelics Policy in New York State (Lucid News)

  • COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK (Psilocybin Alpha)

  • Can Psychedelic Masculinity Stop War? (Lucid News)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.4.22

Cannabis

  • Maryland House Advances Cannabis Legalization Bills (High Times)

  • D.C. Lawmakers Approve Ban On Pre-Employment Marijuana Testing For Most Workers (Marijuana Moment)

  • Where does Biden’s Supreme Court nominee stand on marijuana legalization? Here’s what we found (Leafly)

  • Medicinal Cannabis Flower Sales Begin In Minnesota (High Times)

  • Virginia House Committee Kills Bill To Begin Marijuana Sales This Year (Marijuana Moment)

  • Rhode Island Lawmakers Introduce Cannabis Legalization Bill (High Times)

  • NCAA Moves To Lower Marijuana Penalties For Student Athletes And Increase THC Threshold In Drug Tests (Marijuana Moment)

  • Nebraska Medical Cannabis Bill Fizzles in Committee (High Times)

  • Get ready for the Northeast to become cannabis country (Politico)

  • France Moves to Begin Cultivating Medical Cannabis (High Times)

  • Virginia lawmakers cracking down on cannabis compound Delta-8 due to safety concerns (WAVY)

  • South Dakota House Rejects Marijuana Legalization Bill That Was Temporarily Revived In ‘Smoke Out’ Vote (Marijuana Moment)

  • Ecuador Kicks Off Medical Cannabis Production (High Times)

  • Washington state to require pesticide testing for adult-use cannabis products (Marijuana Business Daily)

  • Ohio Lawmakers Advance Bill To Allow Medical Cannabis for Autism (High Times)

  • Confusion over CBD for Children (Drug WarRant)

  • Pennsylvania Senate Committee Holds Second Marijuana Legalization Hearing As Reform Bill Is Drafted (Marijuana Moment)

  • Georgia Lawmakers Consider Bill to Expand Medical Pot Program (High Times)

LSD

  • Landmark trial compares LSD and psilocybin trips, finds few differences (New Atlas)

  • Mystical experiences might bridge the gap between LSD-induced “madness” and healing (PsyPost)

Magic Mushrooms

  • Colorado may be the next state to decriminalize ‘magic’ mushrooms (The Durango Herald)

  • Terminal cancer patient denied magic mushrooms after Health Canada rule change (CBC)

  • Psilocybin Leaps Ahead of Other Psychedelics in Trials and Studies (Lucid News)

  • The Plan to Reschedule Psilocybin at the UN (TalkingDrugs)

  • 'We need emergency access': 82 Canadian professionals request psilocybin for therapy training (Vancouver Sun)

  • Oregonians more interested in taking psilocybin for well-being than depression or anxiety (OPB)

  • How Will Oregon Teach and Train Psilocybin Healers? (Filter)

  • Magic mushrooms, psilocybin and microdosing: Growing trend draws e-vendors, scientists (CBC)

MDMA

5-MeO-DMT

  • Could 5-MeO-DMT Allow For More Affordable Psychedelic-Assisted Therapy? Beckley Psytech Thinks So (Forbes)

Iboga

  • MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program (PR Newswire)

Novel Psychoactive Substances

  • PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma (Psilocybin Alpha)

Synthetic Cannabinoids

Ketamine

  • Dr. Bronner’s to Provide Psychedelic-Therapy as Employee Healthcare Benefit (Dr. Bronner's)

  • Ketamine Could Treat Alcohol Use Disorder, Study Shows (Lucid News)

  • Dying to Stay Alive: A Ketamine Disaster (Mad in America)

  • Yale researchers study ketamine as a potential treatment for depression in patients with Parkinson’s disease (Yale Daily News)

  • Adding Lithium Might Enable Ketamine's Antidepressant Activity in Ketamine-Resistant Patients, Study Suggests (Brain and Behavior Research Foundation)

Miscellaneous

  • It’s Time to Start Studying the Downside of Psychedelics (VICE)

  • Utah Psychedelics And Mental Health Bill Heads To Governor’s Desk After Senate Approval (Marijuana Moment)

  • In Oregon, Psychedelics Regulators Confront Conflicts of Interest (VICE)

  • More People Are Microdosing for Mental Health. But Does It Work? (The New York Times)

  • The Need for an International Psychedelic Religious Survey (Psychedelics Today)

  • Psychedelic Therapeutics Market May Receive Federal Approval Before Marijuana Does (MarketWatch)

  • Staring into the Abyss: Examining Venezuela’s Drug Policies (TalkingDrugs)

  • Global Survey: Some Microdosing Individuals Have Altered Psychiatric Drug Dosage (Psychiatry Advisor)

  • How Psychedelics Will Impact Mainstream Product Development (Yahoo!)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.28.22

Cannabis

  • Thailand Becomes First Country in Asia to Decriminalize Marijuana (TIME)

  • New York medical cannabis approved for ‘any’ condition a doctor recommends (Leafly)

  • Mississippi: Lawmakers Advance Medical Cannabis Access Bill to Governor’s Desk (NORML)

  • Amazon Endorses Federal Cannabis Legalization (High Times)

  • Europeans choosing cannabis over ecstasy (The Portugal News)

  • Delaware Lawmakers Approve Marijuana Legalization Bill In Committee Vote (Marijuana Moment)

  • Arkansas voters could see 3 recreational marijuana initiatives on ballot (Marijuana Business Daily)

  • Cannabis Events Come Out of Hiding in New York City (The New York Times)

  • North Dakota recreational marijuana measure fails to qualify for ballot (Marijuana Business Daily)

  • Wisconsin Republicans Announce Limited Medical Marijuana Legalization Bill (Marijuana Moment)

  • Legal Cannabis Opens a Pandora’s Box of Equity Issues (Capital and Main)

  • Ohio Lawmakers Will Be Forced To Consider Marijuana Legalization As State Validates Activist Signatures (Marijuana Moment)

  • Active Ingredient in Cannabis Protects Aging Brain Cells (Neuroscience News)

  • Majority Of Americans Say They’d Vote For A Politician Who Smokes Marijuana, Poll Finds (Marijuana Moment)

  • What Happens When You Quit Cannabis? (IFLScience)

  • Missouri Marijuana Legalization Measures Take Differing Approaches to Expungement (Marijuana Moment)

  • Minnesota Groups Bind Together to Oppose Legal Cannabis (High Times)

  • Don’t Feed Marijuana Buds To Donkeys, New Study Warns (Marijuana Moment)

  • South Dakota: House Lawmakers Move to Repeal Citizen-Initiated Home Cultivation Rights (NORML)

LSD

  • FDA clears phase 2b study of LSD treatment for generalized anxiety (Healio)

Magic Mushrooms

  • No difference between psilocybin microdosing and placebo, trial finds (New Atlas)

  • Colorado Activists File Revised Ballot Initiatives To Legalize Psilocybin And Establish ‘Healing Centers’ (Marijuana Moment)

  • Oregon Lawmakers File Psilocybin Equity Bill As State Implements Legal Use Program (Marijuana Moment)

  • Oklahoma Republicans File Bills To Decriminalize Psilocybin And Encourage Research On Medical Benefits (Marijuana Moment)

  • Numinus Identified as a Licensed Psilocybin Supplier by Health Canada (Psilocybin Alpha)

  • Psilocybin: Following in the Footsteps of Cannabis Along the Path to Legality (JD Supra)

  • Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research Council of Canada (Psilocybin Alpha)

  • How is Oregon Preparing for the Facilitated Use of Psilocybin? (Lucid News)

  • Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program (Psilocybin Alpha)

  • Diamond Therapeutics Looks At Low-Dose Psilocybin (The Dales Report)

  • Mydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in Veterans (Psilocybin Alpha)

DMT

  • Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its Psychedelic Drug DMT Intellectual Property (Psilocybin Alpha)

5-MeO-DMT

  • A Psychedelic Craze Has Taken Hold Among The Rich, Toad Venom (Baller Alert)

Novel Psychoactive Substances

  • The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of (VICE)

  • Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of Addictions (Psilocybin Alpha)

Ketamine

  • New study indicates ketamine is less effective than electroconvulsive therapy for severe depression (PsyPost)

  • Ketamine Intravenous Therapy Shown to Improve Depression, Reduce Suicidal Ideation (Psych Central)

  • Have We Eliminated Stigma Surrounding Ketamine-Assisted Treatment? (Volteface)

Miscellaneous

  • Missouri Legislators Introduce Bill to Give Terminally Ill Patients Access to Psychedelics (DoubleBlind)

  • Virginia House Committee Pushes Back Psychedelics Decriminalization Bill Until 2023, But Senate Proposal Still Pending (Marijuana Moment)

  • Lawmakers Propose Study of Natural Psychedelics for Mental Health Use (Westword)

  • Introducing Vital: Immersive, Inclusive, and Personal Psychedelic Training for Professionals (Psychedelics Today)

  • Psychedelic Perceptions in 2021: Popular Culture & Controversy (Psilocybin Alpha)

  • Family Tripping: How Multigenerational Psychedelic Drug Experiences Can Provide Connection (Everything Zoomer)

  • Psychedelic Capital: Public vs. Private Markets (Truffle Report)

  • Sensible policy on psychedelic drugs is growing more common (The Economist)

  • Inside the Growing Wellness Trend of Psilocybin Mushroom Microdosing (The Hollywood Reporter)

  • Hallucinogen chemistry guides antidepressant drug discovery (Chemical and Engineering News)

  • Decriminalize Nature and Students For Sensible Drug Policy Create a Community Healing Alliance (High Times)

  • Have You Taken Psychedelics? Participate In The Canadian Psychedelics Survey Sponsored By MAPS PBC (The Dales Report)

  • Laganja Estranja’s Psychedelic Life (DoubleBlind)

  • Psychedelics and Parkinson’s Disease: Improving Patient Quality of Life (Truffle Report)

  • Psychedelic and Plant Medicines: A Portal to Transformative Realms of Possibility (Nonprofit Quarterly)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.